{{Rsnum
|rsid=8176720
|Gene=ABO
|Chromosome=9
|position=133257486
|Orientation=minus
|ReferenceAllele=A
|GMAF=0.4275
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABO
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 37.5 | 51.8 | 10.7
| HCB | 30.1 | 46.3 | 23.5
| JPT | 19.6 | 64.3 | 16.1
| YRI | 28.6 | 49.7 | 21.8
| ASW | 22.8 | 50.9 | 26.3
| CHB | 30.1 | 46.3 | 23.5
| CHD | 34.9 | 45.0 | 20.2
| GIH | 27.7 | 50.5 | 21.8
| LWK | 24.5 | 43.6 | 31.8
| MEX | 22.4 | 58.6 | 19.0
| MKK | 44.9 | 41.0 | 14.1
| TSI | 49.0 | 32.4 | 18.6
| HapMapRevision=28
}}

This SNP is in the [[ABO]] gene, and is therefore potentially useful in determing blood group type, such as through the use of [[genosets]].

{{PMID|18940312|OA=1
}} Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.

{{PMID|19169360|OA=1
}} Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity.

{{PMID|19729612|OA=1
}} Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin.

{{GET Evidence
|gene=ABO
|aa_change=His99Arg
|aa_change_short=H99R
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs8176720
|n_genomes=1
|n_genomes_annotated=0
|n_haplomes=1
|n_articles=0
|n_articles_annotated=0
|nblosum100=1
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}